Delta and Korean Air Invest $550 Million in WestJet Airlines Stake

Published 1 days agoDAL

Delta and Korean Air Invest $550 Million in WestJet Airlines Stake

Delta Air Lines and Korean Air have announced a strategic partnership with a combined investment of $550 million in Canada's WestJet Airlines. Delta is set to acquire a 15% stake for $330 million, while Korean Air will invest $220 million for a 10% share, giving them a combined ownership of 25%. This move marks a significant collaboration in the airline industry, aiming to bolster connectivity and market presence.

Despite this major investment, WestJet will remain under the ownership and operational control of Onex Corporation, ensuring continuity in the airline's governance. The collaboration is not entirely new, as Delta and Korean Air have worked closely with WestJet since 2011, including through codeshare agreements and joint ventures, according to Reuters.

This development occurs against a backdrop of economic challenges for airlines, particularly due to reduced U.S.-bound travel from Canada. This decline is attributed to tariffs and political tensions affecting airlines like Air Canada. The investment by Delta and Korean Air comes at a strategic time, aiming to solidify their positions in both North American and Asian markets, potentially providing a much-needed boost to the Canadian airline industry.

Share this article

Twitter Facebook LinkedIn

Recent Articles

Akero Therapeutics Shines with Strong Trial Results and Upgraded Ratings

Akero Therapeutics Shines with Strong Trial Results and Upgraded Ratings

3 minutes agoAKRO

Akero Therapeutics, trading as NASDAQ: AKRO, has made significant strides as a leading healthcare stock, following a successful Phase 2b clinical trial of its drug, efruxifermin (EFX). The SYMMETRY study revealed that 39% of patients on a 50mg dose demonstrated a reversal of compensated cirrhosis over 96 weeks, significantly better than the 15% observed in the placebo group. This promising outcome has drawn attention to Akero's potential in advancing treatment for liver conditions. In response to these developments, several leading financial institutions have upgraded their ratings for Akero's stock, accompanied by considerable increases in price targets. Bank of America has shifted its rating from "neutral" to "buy," boosting the price target from $35.00 to $63.00. Morgan Stanley saw even greater potential, maintaining an "overweight" rating and raising its target from $46.00 to $96.00. UBS Group went further, increasing its price target from $42.00 to $109.00 and giving it a "buy" rating. Moreover, Akero's financial position bolsters its appeal. The company reported $797.8 million in cash and equivalents by the end of 2024, further enhanced by an additional $402.5 million raised in January 2025. This robust financial backing provides Akero with an operational runway well into 2028. Reacting to these financial and clinical successes, Akero's stock surged by 106.57% during the week of January 27–31, 2025, indicating strong investor confidence amid these positive developments.

Renaissance Technologies Significantly Boosts Apple Holdings

Renaissance Technologies Significantly Boosts Apple Holdings

18 minutes agoAAPL

In a notable move, Jim Simons' Renaissance Technologies has increased its investment in Apple Inc. by a staggering 316.2% during the second quarter of 2024. The prominent hedge fund acquired an additional 1,307,877 shares, bringing its total holdings to 1,721,444 shares. This expanded position in the tech giant is valued at approximately $362.58 million. Apple now represents about 0.6% of Renaissance Technologies' overall portfolio and ranks as its 13th largest holding. This significant adjustment underscores the strategic importance of Apple within the firm's diverse investment strategy. Established data from defenseworld.net reveals that these changes are part of a broader pattern of strategic investments in high-profile stocks. Renaissance Technologies has been engaging with Apple shares since 2013, completing 42 transactions entailing 23 purchases and 18 sales. The average purchase price over this period has been $30.93 per share, resulting in an estimated total gain of $1.07 billion to date. With Apple currently trading at $198.53 per share and boasting a market cap of approximately $3.28 trillion as of May 2025, the firm continues to align its quantitative investment strategies with its commitment to capitalize on Apple's market prominence.

Renaissance Technologies and Gilead Sciences: Investment Unclear

Renaissance Technologies and Gilead Sciences: Investment Unclear

33 minutes agoGILD

As of May 2025, there is no publicly accessible information indicating that Renaissance Technologies has identified Gilead Sciences as a top stock pick. The hedge fund, founded by Jim Simons, who passed away in May 2024, is known for its cutting-edge quantitative investing strategies. Gilead Sciences is a leading biopharmaceutical firm known for developing antiviral drugs targeting conditions like HIV/AIDS, hepatitis, and COVID-19. Despite Renaissance Technologies' historical investments across various sectors, including healthcare, specifics on their current investments, such as in Gilead, remain undisclosed. Investment details for Renaissance Technologies are usually kept private, and without official announcements or regulatory filings, it's difficult to ascertain their present stake in companies like Gilead Sciences. For the latest insights into their investment activities, checking their formal communications or SEC filings would be recommended.

Li Auto's Remarkable Growth: A Promising Player in the EV Sector

Li Auto's Remarkable Growth: A Promising Player in the EV Sector

48 minutes agoLI

Li Auto Inc. has demonstrated exceptional growth in the electric vehicle market, particularly with its remarkable delivery figures. In December 2023 alone, the company delivered 50,353 vehicles, marking a staggering 137% increase compared to the same period the previous year. This significant surge in deliveries underscores Li Auto's strong market performance and strategic appeal as a high-growth EV stock, as reported by Nasdaq. Supporting Li Auto's robust growth, the company has made significant strides in expanding its infrastructure and product offerings. It now operates 614 supercharging stations fitted with 2,726 charging stalls across China, catering to the needs of its expanding fleet. Li Auto has also broadened its product spectrum by introducing the Li i8, its first fully electric SUV, thereby diversifying its lineup beyond its existing extended-range models, according to coverage by Fool. Financially, Li Auto's results further cement its status as a formidable contender in the EV landscape. In the third quarter of 2023, the company achieved a 271% year-over-year revenue growth, translating to $4.6 billion, with a notable vehicle gross margin of 21.2% and a robust free cash flow of $1.8 billion. Collaborative ventures, such as its partnership with Nvidia to enhance autonomous driving technology, also reflect the company's strategic initiatives aimed at sustaining its upward trajectory.